Ocular Features in Neurosarcoidosis
暂无分享,去创建一个
[1] 陶仲为. Sarcoidosis , 2009 .
[2] L. Labree,et al. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. , 2007, Ophthalmology.
[3] Jean-Marc Constans,et al. Reduced thalamic and cerebellar rest metabolism in relapsing–remitting multiple sclerosis, a positron emission tomography study: Correlations to lesion load , 2006, Journal of the Neurological Sciences.
[4] B. Schlosshauer,et al. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. , 2005, Investigative ophthalmology & visual science.
[5] R. Nussenblatt,et al. Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome. , 2005, American journal of ophthalmology.
[6] E. Hoitsma,et al. Neurosarcoidosis: a clinical dilemma , 2004, The Lancet Neurology.
[7] G. Jaffe,et al. Demographic-related variations in posterior segment ocular sarcoidosis. , 2004, Ophthalmology.
[8] L. Bielory,et al. Sarcoidosis of the Anterior Visual Pathway: 24 New Cases , 2003, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[9] John W VanMeter,et al. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT): Clinical Applications. , 2003, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[10] R. Bakshi,et al. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis , 2002, Journal of the Neurological Sciences.
[11] R. Schwartzman,et al. CSF-ACE activity in probable CNS neurosarcoidosis. , 2002, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[12] P. Kaiser,et al. Chest computerized tomography in the evaluation of uveitis in elderly women. , 2002, American journal of ophthalmology.
[13] G. McLennan,et al. Clinical characteristics of patients in a case control study of sarcoidosis. , 2001, American journal of respiratory and critical care medicine.
[14] M. Trojano,et al. The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes , 2001, Neurological Sciences.
[15] S. Lightman,et al. Symptomatic intraocular inflammation in multiple sclerosis , 2000, Clinical & experimental ophthalmology.
[16] G. Soubrane,et al. Neuropathie optique sarcoïdosique , 1999 .
[17] J. Dale,et al. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. , 1999, Mayo Clinic proceedings.
[18] M. Recio,et al. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. , 1999, AJNR. American journal of neuroradiology.
[19] M. Rovaris,et al. Central nervous system sarcoidosis--diagnosis and management. , 1999, QJM : monthly journal of the Association of Physicians.
[20] S. Orengo-Nania,et al. Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri. , 1999, American journal of ophthalmology.
[21] V. Biousse,et al. Multiple sclerosis associated with uveitis in two large clinic-based series , 1999, Neurology.
[22] W R Kinkel,et al. High‐Resolution Fluorodeoxyglucose Positron Emission Tomography Shows Both Global and Regional Cerebral Hypometabolism in Multiple Sclerosis , 1998, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[23] M. Meziane,et al. Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis. , 1998, American journal of ophthalmology.
[24] M. Yamaguchi,et al. Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? , 1997, Clinics in chest medicine.
[25] S. Harding,et al. Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis. , 1996, Archives of ophthalmology.
[26] B. Stern,et al. Therapeutic considerations in patients with refractory neurosarcoidosis. , 1995, Archives of neurology.
[27] N. Newman,et al. Optic nerve enlargement and chronic visual loss. , 1994, Survey of ophthalmology.
[28] M. Lv,et al. Sarcoidosis and its ocular manifestations , 1994 .
[29] Sharma Op,et al. Role of magnetic resonance imaging in neurosarcoidosis. , 1993 .
[30] A. Rothova,et al. Fundus pathology in neurosarcoidosis , 1993, International Ophthalmology.
[31] E. Tozman,et al. Sarcoidosis: clinical manifestations, epidemiology, therapy, and pathophysiology , 1991, Current opinion in rheumatology.
[32] D. Laplane,et al. Neurosarcoidosis: Signs, Course and Treatment in 35 Confirmed Cases , 1990 .
[33] R. Spaide,et al. Conjunctival biopsy in the diagnosis of sarcoidosis. , 1990, The British journal of ophthalmology.
[34] N. Milman,et al. Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. , 1990, Sarcoidosis.
[35] J. Goust,et al. Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis , 1989, Neurology.
[36] A. Rothova,et al. Risk factors for ocular sarcoidosis , 1989, Documenta Ophthalmologica.
[37] R. Mckendall,et al. Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. , 1989, Archives of neurology.
[38] E. Huhti,et al. Course and outcome of ocular sarcoidosis. , 1988, American journal of ophthalmology.
[39] V. Oksanen. New cerebrospinal fluid, neurophysiological and neuroradiological examinations in the diagnosis and follow-up of neurosarcoidosis. , 1987, Sarcoidosis.
[40] D. Jabs,et al. Ocular involvement in chronic sarcoidosis. , 1986, American journal of ophthalmology.
[41] B. Stern,et al. Sarcoidosis and its neurological manifestations. , 1985, Archives of neurology.
[42] F. Fyhrquist,et al. CSF ANGIOTENSIN-CONVERTING ENZYME IN NEUROSARCOIDOSIS , 1985, The Lancet.
[43] E. Spokes,et al. CSF ANGIOTENSIN-CONVERTING ENZYME IN NEUROSARCOIDOSIS , 1985, The Lancet.
[44] L. Caplan,et al. Neuro‐ophthalmologic signs in the angiitic form of neurosarcoidosis , 1983, Neurology.
[45] R. Christenson,et al. Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. , 1983, Clinical chemistry.
[46] H. Manz. Pathobiology of Neurosarcoidosis and Clinicopathologic Correlation , 1983, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[47] J. Selhorst,et al. Sarcoid optic neuropathy , 1982, Neurology.
[48] M. Sanders,et al. Fundus changes in histologically confirmed sarcoidosis. , 1981, The British journal of ophthalmology.
[49] G. Klintworth,et al. Sarcoidosis and its ophthalmic manifestations. , 1978, American journal of ophthalmology.
[50] P. Delaney. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. , 1977, Annals of internal medicine.
[51] Maddocks Ac. Letter: Sterilisation of cardiac bioptome. , 1974 .
[52] H. Herlinger,et al. Letter: Immunoglobulin standards. , 1974 .
[53] L. Siltzbach. The Kveim test in sarcoidosis. A study of 750 patients. , 1961, JAMA.
[54] E. Hoitsma,et al. Neurological Manifestations of Sarcoidosis , 2005 .
[55] K. Digre,et al. Neuro-ophthalmic Complications of Sarcoidosis , 2000, Seminars in neurology.
[56] A. Glacet-Bernard,et al. [Sarcoid optic neuropathy]. , 1999, Journal francais d'ophtalmologie.
[57] J. Leavitt,et al. Cost-effectiveness in the diagnosis of sarcoidosis: The conjunctival biopsy , 1998, Eye.
[58] L. Messner,et al. Sarcoidosis and its ocular manifestations. , 1994, Journal of the American Optometric Association.
[59] J. Kadakia,et al. Role of magnetic resonance imaging in neurosarcoidosis. , 1993, Sarcoidosis.
[60] L. A. K. Bastiaensen,et al. Conjunctival sarcoidosis , 1985, Documenta Ophthalmologica.